Search Results

A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator’s Choice Therapy in Participants with Relapsed Small Cell Lung Cancer MOA: ZL-1310 is an ADC that targets DLL3 and contains a topoisomerase I inhibitor payload Key Eligibility Criteria: Confirmed diagnosis of SCLC Archival tumor tissue or fresh tumor tissue…

Reid Sullivan has been working as a physician assistant with a focus in oncology since 2025. She received her bachelor’s degree in Neurobiology and Physiology at the University of Maryland College Park. Reid then went on to earn her master’s degree in Physician Assistant Studies at the University of Pittsburgh. She is board certified by…

We are pleased to share some exciting news with our patients and community. Maryland Oncology Hematology’s Frederick office will be moving to a new, upgraded location on March 23, 2026. The new space is conveniently located just down the street on Thomas Johnson Drive, ensuring an easy and seamless transition for all who visit us.…

Rylie Chambers, MSN, AGPCNP-BC, OCN is a board-certified Adult-Geriatric Primary Care Nurse Practitioner with a specialization in oncology. She graduated magna cum laude from Indiana University of Pennsylvania earning her Bachelor of Science in Nursing and recognition as a provost scholar from her accredited nursing program. Rylie went on to complete her Master of Science…